跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler - TGA Drug Approval Details
Approvals
/
TGA
/
IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Approved
STANDARD
IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7601d033d773c989
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7601d033d773c989
Product Name
IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Artg Id
410013
Artg Name
IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2025-05-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7601d033d773c989
Type
Standard
Back to TGA Approvals
